Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Apr 13, 2021 3:07pm
88 Views
Post# 32986616

RE:RE:RE:THRM vague news! , Moving my money to PRSN is up 25%

RE:RE:RE:THRM vague news! , Moving my money to PRSN is up 25%The numbers were in the THRM Admin post on here this morning. 100% Sensitivity and 100% Specificity.

....and from the NR this morning

"Dr. Ricardo Fujiwara, from the Federal University of Minas Gerais, stated that, "The AcuVid™ initial results confirm the sensitivity and specificity results achieved in Therma's development studies of the AcuVid™ test against the SARS-CoV-2...."

flight100 wrote: Where are the numbers?

https://stockhouse.com/news/press-releases/2021/04/13/therma-bright-provides-update-on-brazilian-performance-study-of-its-acuvid-tm


<< Previous
Bullboard Posts
Next >>